31 – 40 of 87
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Sexual Function in Men Treated for Testicular Cancer.
(
- Contribution to journal › Article
-
Mark
Feelings of loss and shame after having lost a testicle: a population-based long-term follow-up of testicular-cancer survivors
2009) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology In EJC Supplements 7(2). p.445-445(
- Contribution to journal › Published meeting abstract
-
Mark
Dose-dense induction followed by autologous stem cell transplant (ASCT) leads to sustained remissions in a large fraction of patients with previously untreated peripheral t-cell lymphomas (PTCLS) - overall and subtype-specific results of a phase II study from the nordic lymphoma group
2009) 14th Annual Meeting of the European-Hematology-Association In Haematologica-The Hematology Journal 94. p.1082-1082(
- Contribution to journal › Published meeting abstract
-
Mark
LONG-TERM IMPAIRED LANGUAGE AND DECREASED WELL-BEING AMONG TESTICULAR CANCER SURVIVORS WHO RECEIVED CHEMOTHERAPY - RESULTS FROM SWENOTECA
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.358-358(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study
(
- Contribution to journal › Article
-
Mark
European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part I
(
- Contribution to journal › Scientific review
-
Mark
Risk factors for post-treatment hypogonadism in testicular cancer patients.
(
- Contribution to journal › Article
-
Mark
Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma.
(
- Contribution to journal › Article
-
Mark
A Subset of CD5- Diffuse Large B-Cell Lymphomas Expresses Nuclear Cyclin D1 With Aberrations at the CCND1 Locus.
(
- Contribution to journal › Article
-
Mark
Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients
(
- Contribution to journal › Article